Kim D. Blickenstaff, Director at TANDEM DIABETES CARE INC (TNDM), sold 398,900 shares at $87.10 ($34.8M) on 2021-03-15, disclosed to the SEC on 2021-03-17.
Open-market sale of $34.8M TNDM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.10 | 135,934 | $11.8M | 34.0% |
| 2 | $87.10 | 135,934 | $11.8M | 34.0% |
| 3 | $87.85 | 13,044 | $1.1M | 3.3% |
| 4 | $87.85 | 13,044 | $1.1M | 3.3% |
| 5 | $85.96 | 5,500 | $473K | 1.4% |
| 6 | $85.96 | 5,500 |
| $473K |
| 1.4% |
| 7 | $87.19 | 20,594 | $1.8M | 5.2% |
| 8 | $87.19 | 20,594 | $1.8M | 5.2% |
| 9 | $88.18 | 23,828 | $2.1M | 6.0% |
| 10 | $88.18 | 23,828 | $2.1M | 6.0% |
| 11 | $88.85 | 1,100 | $98K | 0.3% |
| Total | $87.26 avg | 398,900 | $34.8M | 100% |
| Filing → |
| TNDM | SELL | 2022-05-19 | $2.0M | — | Filing → |
| TNDM | SELL | 2021-09-03 | $3.3M | — | Filing → |
| TNDM | SELL | 2021-08-18 | $8.8M | — | Filing → |